{
    "ucits": true,
    "type": "ETF",
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": true,
    "replication_method": "synthetic",
    "complex_factors": "Leverage, Inverse exposure, Synthetic replication, Use of derivatives including swaps, Daily rebalancing compounding effects, High risk profile",
    "classification": "complex",
    "supporting_data": "The product is a Leverage Shares -5x Short 20+ Year Treasury Bond ETP Securities, which is a collateralised exchange traded security (ETP), not a UCITS ETF. It aims to provide -5 times the daily performance of the iShares 20+ Year Treasury Bond ETF, implying significant leverage and inverse exposure. The product uses derivatives (likely swaps or similar instruments) to achieve this leveraged inverse exposure, which introduces counterparty and collateral risks. The daily rebalancing and compounding effects further complicate the risk-return profile, making it difficult for retail investors with basic knowledge to understand. The product is explicitly described as high risk (risk class 7/7), non-principal protected, and not simple to understand, with a mandatory comprehension alert in the KID. The replication method is synthetic, relying on derivatives rather than physical holdings. These features align with MiFID II Article 254 and Delegated Regulation EU 2017/565 Article 57 criteria for complex instruments, as derivatives are integral to the investment objective, leverage is significant, and the structure is opaque and difficult to understand. Therefore, despite being an ETP, it is complex under MiFID II rules."
}